medline.ch Onkologie Blut

	Exploring mixed phenotype acute leukemia: Clinical, immunophenotypic, cytogenetic, and prognostic insights from a tertiary care center. Indian J Pathol Microbiol Sarjana, Jasmita, Agarwal M, Ganesh V, Mahapatra M. PMID: 41913419 [PubMed - indexed for MEDLINE]
	Patients' and healthcare providers' views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study. Oncologist Lokhorst DN, van den Bemt BJF, Smit Y, Hermens RPMG, Blijlevens NMA, Bekker CL. PMID: 41913063 [PubMed - as supplied by publisher]
	HSR26-241: Prophylactic G-CSF (Granulocyte Colony-Stimulating Factor) in AML (Acute Myeloid Leukemia) Induction: A Meta-Analysis Dispelling Relapse Concerns and Reinforcing Supportive Benefit. J Natl Compr Canc Netw Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J. PMID: 41911849 [PubMed - in process]
	HSR26-227: Post-Allogenic Hematopoietic Stem Cell Transplant (Allo-HSCT), Hypomethylating-Agent Maintenance Improves Survival Without Increasing GVHD (Graft Versus Host Disease) in AML/MDS (Acute Myeloid Leukemia/Myelodysplastic Syndrome): Updated Systematic Review and Meta-Analysis. J Natl Compr Canc Netw Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J. PMID: 41911838 [PubMed - in process]
	HSR26-228: BTK Inhibitor (Bruton Tyrosine Kinase Inhibitor) Plus Anti-CD20 Antibody Therapy Surpasses CIT (Chemoimmunotherapy) in Frontline CLL (Chronic Lymphocytic Leukemia) With Obinutuzumab Drives Deeper Remissions: A Meta-Analysis of Randomized Controlled Trials. J Natl Compr Canc Netw Sharma A, Daid SS, Sharma A, Meseeha M, Poulose J. PMID: 41911756 [PubMed - in process]
	CLO26-106: From Vasculitis to NK/T-Cell Lymphoma: A Complex Diagnosis in a Patient With a Midline Tumor and Positive ANCA. J Natl Compr Canc Netw Hernández I, Vargas LP, León JMM, Ballesteros-García MC, Bacca J, Ferro JD, Dorado L, Santoyo-Sarmiento N. PMID: 41911732 [PubMed - in process]
	Transforming Acute Myeloid Leukemia Care Through Precision Medicine: Integrating Genomic Profiling, Measurable Residual Disease, and Targeted Therapies. Oncology Al-Shibly R, Benkhadra M, Yassin MA. PMID: 41911081 [PubMed - as supplied by publisher]
	LM-101, an anti-SIRPÎ± antibody, in patients with relapsed/refractory lymphoma and advanced head and neck cancer: an open-label, multicenter, phase 1 trial. Clin Cancer Res Cai J, Zhao B, Ji D, Zhou F, Bai S, Fang X, Nie M, Bai B, Zhang Y, Li J, Li H, Li Y, Fei D, Qin X, Qin C, Zhao S, Xia Y, Cai Q. PMID: 41910591 [PubMed - as supplied by publisher]
	Pharmacokinetics, efficacy, and safety of arsenic formulations in acute promyelocytic leukemia treatment. Expert Rev Clin Pharmacol Marvin-Peek J, Jen WY, Ravandi F. PMID: 41910474 [PubMed - as supplied by publisher]
	Aggressive extramedullary acute myeloid leukaemia masquerading as dental infection with rare t(10:11) translocation and subsequent relapse as leukaemia cutis. J Cancer Res Ther Pustake M, Kalas M, Valles-Gamez R, Eysha M, Didia SC, Gaur S. PMID: 41910305 [PubMed - indexed for MEDLINE]
	A phase I open label study of fostamatinib, a SYK inhibitor, in patients with lower-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Leuk Lymphoma Croden J, Garcia-Manero G, Chien K, DiNardo C, Borthakur G, Hammond D, Bose P, Short N, Romero L, Shneider H, Hatfield M, Pierce S, Huang X, Hwang H, Montalban-Bravo G. PMID: 41909958 [PubMed - as supplied by publisher]
	Dupilumab and cutaneous T-cell lymphoma: A retrospective cohort study. JAAD Int Baghdasarian S, Al-Saedi O, Cuomo RE. PMID: 41907483 [PubMed]
	Allogeneic transplant outcomes in T-cell prolymphocytic leukemia: a single-center retrospective study. Leuk Lymphoma Merrill M, Kim HT, Kelkar AH, Panaro K, Tamada R, Au C, Singh S, Vicks A, Jain S, Ritz J, Ho VT, Jacobsen E. PMID: 41906811 [PubMed - as supplied by publisher]
	Nationwide Incidence, Treatment Pattern, and Prognosis of Primary CNS Lymphoma in Taiwan, 2012-2020: A Retrospective Cohort Study. Cancer Med Hsiao FY, Lin HY, Chen HM, Hsu WH, Ko BS. PMID: 41906256 [PubMed - indexed for MEDLINE]
	Efficacy and safety of ATRA plus arsenic trioxide versus ATRA plus chemotherapy in newly diagnosed acute promyelocytic leukemia: a grade-assessed systematic review and meta-analysis. BMC Cancer Ahmad H, Henna F, Khurram S, Khan A, Ahmed A, Ali MH, Hassan MA, Abbas M, Farooq D, Muhammad S, Basit AA, Ahmad A. PMID: 41906112 [PubMed - as supplied by publisher]
	Cross-platform deep learning enables automated cytomorphologic subtyping of acute leukemia from bone marrow smears. Virchows Arch Wang G, Chen W, Zhao H, Chen X, Wu M, Yu Q, Liu Q, Liu H, Song E, Xue M, Sun C, Chu Z, Hu Y. PMID: 41906037 [PubMed - as supplied by publisher]
	Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration. Br J Haematol Caserta S, Martino EA, Skafi M, Alvaro ME, Bruzzese A, Amodio N, Fiorillo M, Lucia E, Olivito V, Labanca C, Mendicino F, Vigna E, Morabito F, Gentile M. PMID: 41905770 [PubMed - as supplied by publisher]
	Phase I Trial of Venetoclax and BEAM followed by Autologous Stem Cell Transplant for High-Risk non-Hodgkin Lymphoma. Transplant Cell Ther Maakaron JE, Zhao Q, Balakrishna JP, Puto M, Penza S, Maddocks KJ, Efebera YA, Saad A, deLima M, Devine S, Jaglowski S, William BM. PMID: 41905702 [PubMed - as supplied by publisher]
	Leukemia Diagnosis 2.0: Revolutionizing advanced and Futuristic Point-of-Care Detection and Monitoring. Crit Rev Oncol Hematol Rizwan A, Shamshad A, Hasan MR, Naikoo UM, Naithani D, Narang J, Farooqi H. PMID: 41905569 [PubMed - as supplied by publisher]
	Malignant transformation in patients with monoclonal gammopathy of undetermined significance treated with teriparatide for osteoporosis: a bicenter retrospective study and analysis of the French national pharmacovigilance database. Arch Osteoporos Cassez R, Cortet B, Bouvard B, Theis D, Potey C, Manier S, Paccou J, Philippoteaux C. PMID: 41904726 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 166850

Seite 1 von 8343

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung